electroCore's Commitment to Health and Wellness
ROCKAWAY, N.J. – electroCore, Inc. (NASDAQ: ECOR), a pioneer in bioelectronic medicine, is gearing up to showcase its innovations at an upcoming health technology event. The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum promises to be a pivotal occasion for the company to engage with key stakeholders in the healthcare industry.
Event Participation Details
Management at electroCore will be actively involved in one-on-one meetings at the forum, facilitating valuable discussions about the future of bioelectronic therapies. Investors interested in attending these discussions are advised to connect with their sales representative at Canaccord Genuity, or they can reach out to the electroCore Investor Relations team for more details.
About electroCore, Inc.
Founded on the principle of enhancing health and well-being through innovative technology, electroCore has made significant strides in the wellness sector. The company specializes in non-invasive bioelectronic therapies designed to treat chronic pain syndromes. Its flagship products, gammaCore and Quell, utilize vagus nerve stimulation and neuromodulation technologies that have been FDA cleared for use.
Innovative Solutions for Chronic Pain Management
Whether it's managing everyday discomfort or chronic pain conditions, electroCore’s products aim to provide a new approach that minimizes reliance on traditional medications. The gammaCore device, for example, is the first of its kind to offer such treatment without the need for surgical intervention.
Focus on General Wellness and Performance
In addition to their prescription offerings, electroCore also markets personal-use devices like Truvaga and TAC-STIM, which leverage bioelectronic technology to enhance overall wellness and improve human performance. As wellness continues to intertwine with technology, electroCore is at the forefront, demonstrating how these innovative tools can positively impact daily life.
Investor Relations and Contact Information
For those who want to learn more about the investor opportunities or have inquiries related to the company, they can get in touch with electroCore by calling (973) 302-9253, or they can reach them via email at investors@electrocore.com. The company invites all interested parties and stakeholders to explore their range of solutions tailored for improved health outcomes.
Frequently Asked Questions
What is the Canaccord Genuity Forum?
The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum is an event that facilitates discussions among industry leaders focused on health technology innovations.
What products does electroCore offer?
electroCore provides innovative bioelectronic devices aimed at managing chronic pain and enhancing general wellness, including gammaCore, Truvaga, and TAC-STIM.
How can investors engage with electroCore?
Investors can schedule meetings with electroCore management representatives during the forum or contact the Investor Relations team directly for inquiries.
What is the primary mission of electroCore?
The mission of electroCore is to enhance health and quality of life through innovative non-invasive bioelectronic therapies targeting chronic pain and wellness.
Where can I find more information about electroCore?
For further details on their products and initiatives, potential investors and interested parties can visit www.electrocore.com.
